Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.

Animals Antineoplastic Agents / chemistry Cobalt Radioisotopes Copper Radioisotopes Humans Male Mice Neoplasms, Experimental / diagnostic imaging PC-3 Cells Positron Emission Tomography Computed Tomography Prostatic Neoplasms / diagnostic imaging Receptors, Bombesin / antagonists & inhibitors
Co-55 Cu-64 NODAGA NOTA PET-imaging RM26 bombesin antagonist gastrin-releasing peptide receptor prostate cancer

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 25 11 2020
revised: 15 12 2020
accepted: 15 12 2020
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 8 9 2021
Statut: epublish

Résumé

Gastrin-releasing peptide receptor (GRPR) is overexpressed in the majority of prostate cancers. This study aimed to investigate the potential of

Identifiants

DOI: 10.3390/molecules25245993 PMID: 33352838 PMC: PMC7766840
pubmed: 33352838
pii: molecules25245993
doi: 10.3390/molecules25245993
pmc: PMC7766840
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Cobalt Radioisotopes 0
Cobalt-55 0
Copper Radioisotopes 0
Copper-64 0
Receptors, Bombesin 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swedish Research Council
ID : 2019-00986
Organisme : Cancerfonden
ID : 2017/425
Organisme : Cancerfonden
ID : 2018/436

Références

Biomed Pharmacother. 2017 Mar;87:58-72
pubmed: 28040598
Biochim Biophys Acta. 2010 May;1800(5):487-510
pubmed: 20153401
Eur Urol. 2017 Apr;71(4):630-642
pubmed: 27591931
PLoS One. 2013 Aug 01;8(8):e70028
pubmed: 23936372
Contrast Media Mol Imaging. 2017 Aug 10;2017:6873684
pubmed: 29097932
Nucl Med Biol. 2010 Oct;37(7):751-61
pubmed: 20870150
Prostate. 2009 Jul 1;69(10):1101-8
pubmed: 19343734
Neurochem Res. 2016 Oct;41(10):2797-2809
pubmed: 27412117
Nucl Med Biol. 2009 Aug;36(6):579-85
pubmed: 19647163
Peptides. 2015 Oct;72:128-44
pubmed: 25976083
Int J Cancer. 2019 Dec 15;145(12):3347-3358
pubmed: 31077356
Expert Opin Ther Targets. 2016 Sep;20(9):1055-73
pubmed: 26981612
Theranostics. 2014 Feb 01;4(4):412-9
pubmed: 24578724
Am J Nucl Med Mol Imaging. 2013;3(1):85-96
pubmed: 23342303
Prostate. 2014 Feb;74(2):217-24
pubmed: 24150752
Curr Drug Deliv. 2011 Jan;8(1):79-134
pubmed: 21034419
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1386-96
pubmed: 20182713
Mol Imaging Biol. 2016 Jun;18(3):368-76
pubmed: 26561028
Curr Radiopharm. 2018;11(1):22-33
pubmed: 29231149
Sci Rep. 2019 Nov 19;9(1):17086
pubmed: 31745219
Nucl Med Biol. 2009 Feb;36(2):171-81
pubmed: 19217529
Cancer Biother Radiopharm. 2009 Aug;24(4):379-93
pubmed: 19694573
Prostate. 1994 Jul;25(1):29-38
pubmed: 8022709
PET Clin. 2017 Apr;12(2):205-217
pubmed: 28267454
Molecules. 2014 Jul 17;19(7):10455-72
pubmed: 25036155
Eur J Nucl Med Mol Imaging. 2016 May;43(5):964-973
pubmed: 26631238
Mol Pharm. 2015 Aug 3;12(8):2781-90
pubmed: 26132879
J Nucl Med. 2020 Jun;61(6):792-798
pubmed: 32060215
Clin Radiol. 2008 Apr;63(4):387-95
pubmed: 18325358
Anticancer Agents Med Chem. 2007 May;7(3):271-90
pubmed: 17504155
Nucl Med Biol. 2018 Jan;56:31-38
pubmed: 29154145
Contrast Media Mol Imaging. 2017 Feb 28;2017:8565802
pubmed: 29097939
Clin Cancer Res. 2009 Aug 15;15(16):5240-9
pubmed: 19671861
J Nucl Med. 2017 Mar;58(3):451-457
pubmed: 27660147
Mol Imaging Biol. 2018 Aug;20(4):501-509
pubmed: 29256046
Curr Med Chem. 2020;27(41):7090-7111
pubmed: 32164503
Int J Biochem Cell Biol. 2019 Sep;114:105567
pubmed: 31295552
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Prostate. 2012 Feb;72(3):318-25
pubmed: 21739464
Ann Oncol. 2007 Sep;18(9):1457-66
pubmed: 17351255
Bioconjug Chem. 2013 Jul 17;24(7):1144-53
pubmed: 23763444
Radiology. 2011 Jun;259(3):852-61
pubmed: 21493787
Am J Nucl Med Mol Imaging. 2014 Sep 06;4(6):580-601
pubmed: 25250207
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Nucl Med. 2008 Feb;49(2):318-26
pubmed: 18199616
J Nucl Med. 2014 Oct;55(10):1719-25
pubmed: 25146125
Int J Oncol. 2016 May;48(5):2124-34
pubmed: 26983776
Cell Cycle. 2010 May;9(9):1738-41
pubmed: 20473035
Q J Nucl Med Mol Imaging. 2008 Jun;52(2):185-92
pubmed: 18043536
J Nucl Med. 2020 Feb;61(2):228-233
pubmed: 31519803
J Labelled Comp Radiopharm. 2017 Apr;60(4):200-212
pubmed: 28129446
Nucl Med Biol. 2015 May;42(5):446-454
pubmed: 25684649
Am J Nucl Med Mol Imaging. 2014 Jun 07;4(4):365-84
pubmed: 24982822

Auteurs

Christina Baun (C)

PET & Cyclotron Centre, Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
ORCID: 0000-0002-5199-9200

Bogdan Mitran (B)

Department of Medicinal Chemistry, Faculty of Pharmacy, Uppsala University, 75183 Uppsala, Sweden.

Sara S Rinne (SS)

Department of Medicinal Chemistry, Faculty of Pharmacy, Uppsala University, 75183 Uppsala, Sweden.
ORCID: 0000-0003-2141-3982

Johan H Dam (JH)

PET & Cyclotron Centre, Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
ORCID: 0000-0001-6577-7011

Birgitte B Olsen (BB)

PET & Cyclotron Centre, Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
ORCID: 0000-0002-6130-0387

Vladimir Tolmachev (V)

Department of Immunology, Genetic and Pathology, Uppsala University, 75185 Uppsala, Sweden.
Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
ORCID: 0000-0002-6122-1734

Anna Orlova (A)

Department of Medicinal Chemistry, Faculty of Pharmacy, Uppsala University, 75183 Uppsala, Sweden.
Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, 75237 Uppsala, Sweden.
ORCID: 0000-0001-6120-2683

Helge Thisgaard (H)

PET & Cyclotron Centre, Department of Nuclear Medicine, Odense University Hospital, 5000 Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
ORCID: 0000-0001-9492-448X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Cobalt › Isotopes du cobalt › Radio-isotopes du cobalt › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du cuivre › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Techniques d'investigation › Modèles animaux › Tumeurs expérimentales › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules PC-3 › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital mâle › Tumeurs de la prostate › Preclinical Evaluation of the Copper-64...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur aux neuropeptides › Récepteur bombésine › Preclinical Evaluation of the Copper-64...